Skip to main content
. 2017 Jun 7;88(2):59–67. doi: 10.5414/CN109021

Figure 2. Change in distribution of patients across different serum phosphorus categories at baseline and during sucroferric oxyhydrase (SO) treatment.

Figure 2.